iProgen Biotech Inc. was founded in 2008 to develop intracellular protein therapeutics. Since then, we have developed a powerful protein drug delivery platform, on which the pharmaceutical industry can build innovative first-in class drugs for battling a variety of diseases of unmet medical needs. Our goal at iProgen is to move forward to clinical development. Through tireless efforts, we selected drugs that showcase our technology while encouraging the pharmaceutical companies to adopt our technology for other existing drug candidates. We are committed to developing and expanding new classes of drugs that are delivered intracellularly by cell-penetrating proteins. We are focused on the development of safe and efficient intracellular protein delivery. We are developing multiple therapeutic candidates in collaboration with academic research institutions. We are seeking industry partners interested in exploring the largely untapped category of intracellular protein therapeutics.